伴与不伴瘤内纤维化的胰腺神经内分泌肿瘤患者动态增强CT强化模式及生存比较
回顾性匹配分析45例伴瘤内纤维化与45例不伴纤维化的胰腺神经内分泌肿瘤患者,比较动态增强CT表现与生存。伴纤维化组呈渐进性强化模式且总生存期更低,不伴纤维化组呈早期强化及廓清模式。
要点
- 伴瘤内纤维化的pNET呈渐进性强化模式,不伴纤维化者呈早期强化及廓清模式。
- 伴纤维化组平扫CT值及肿瘤/正常胰腺实质CT值比值均高于不伴纤维化组。
- 伴纤维化组动脉期CT值及比值低于不伴纤维化组,且总生存期更低。
核心结论
- 伴瘤内纤维化的pNET表现为渐进性强化模式,且总生存期显著低于不伴纤维化者(后者呈早期强化及廓清模式)。
研究设计与样本
- 回顾性研究,按年龄、性别、肿瘤大小及分级匹配45例伴瘤内纤维化pNET患者(A组)与45例不伴纤维化pNET患者(B组),比较动态增强CT图像及生存。
关键影像表现/征象
- A组呈渐进性强化模式,B组呈早期强化及廓清模式(p < 0.05)。
- A组平扫期肿瘤CT值及肿瘤/正常实质CT值比值显著高于B组(p ≤ 0.024)。
- A组动脉期肿瘤CT值及比值显著低于B组(p ≤ 0.003)。
- A组更常见周边向完全强化或周边向周边强化变化,B组更常见完全向完全强化变化(p < 0.05)。
诊断标准与关键数值
- 强化模式比较:A组渐进性强化 vs B组早期强化及廓清(p < 0.05)。
- 平扫期肿瘤CT值及肿瘤/正常实质CT值比值:A组高于B组(p ≤ 0.024)。
- 动脉期肿瘤CT值及比值:A组低于B组(p ≤ 0.003)。
- 强化变化模式:A组周边向完全或周边向周边强化更常见,B组完全向完全强化更常见(p < 0.05)。
- 总生存期:A组显著低于B组(p = 0.029)。
临床应用与阅片要点
- 阅片时注意pNET的强化模式:渐进性强化提示可能伴瘤内纤维化,早期强化及廓清提示不伴纤维化。
- 平扫CT值较高而动脉期CT值较低,结合强化模式变化,可能提示瘤内纤维化存在。
- 伴瘤内纤维化的pNET患者总生存期更低,可与临床沟通时参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare CT findings and survival between patients with pancreatic neuroendocrine tumors (pNETs) with and without fibrosis.
METHODS: Forty-five pNET patients with intratumoral fibrosis (group A) were matched for age, gender, and tumor size and grade with 45 pNET patients without (group B), and CT images were retrospectively reviewed. Hounsfield units (HUs) of tumors in unenhanced, arterial and portal phases, HU ratio (tumor to normal parenchyma) in each phase, enhancement patterns, visible enhancement pattern changes, and survival were compared.
RESULTS: Group A showed progressive enhancement patterns, while group B showed early enhancement and wash-out patterns (p < 0.05). HUs of tumors and HU ratio in the unenhanced phase were significantly higher in group A than group B (p ≤ 0.024), whereas those in the arterial phase were significantly lower in group A than group B (p ≤ 0.003). Peripheral to full or peripheral to peripheral enhancement change was more frequent in group A, while full to full enhancement change was more frequent in group B (p < 0.05). Group A showed significantly lower overall survival than group B (p = 0.029).
CONCLUSIONS: pNETs with fibrosis showed a progressive enhancement pattern and worse overall survival than pNETs without, which showed an early enhancement and wash-out pattern.
引用
- Kim C, Byun JH, Hong SM, et al. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis. Abdom Radiol (NY). 2017. PMID: 28624923. doi:10.1007/s00261-017-1212-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。